Figure 1.
Response to PV after CAR T-cell therapy in LBCL. NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.

Response to PV after CAR T-cell therapy in LBCL. NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.

Close Modal

or Create an Account

Close Modal
Close Modal